Bio-Techne Expands Spatial Biology Capabilities with Modular Enhancement of the COMET™ Suite
Bio-Techne Corporation has announced a significant expansion of its spatial biology capabilities with the introduction of new tools within its COMET™ technology platform. The launch of SPYRE™ Focus Panels and SPYRE™ Amplification Kits marks a major step forward in enhancing the flexibility, sensitivity, and overall performance of spatial biology workflows. These additions are designed to help researchers extract deeper biological insights from complex tissue samples, supporting advances in translational research and preclinical therapeutic development.
The COMET platform is Bio-Techne’s modular and automated spatial biology solution, enabling scientists to analyze tissue samples at high resolution while preserving spatial context. Spatial biology has become an increasingly important field in life sciences, particularly in areas such as oncology, immunology, and drug discovery, where understanding the interactions between cells within their native environment is critical. By expanding the COMET ecosystem, Bio-Techne aims to provide researchers with more powerful tools to interrogate biological systems with precision and efficiency.
At the core of this expansion are the SPYRE Focus Panels, a new generation of modular antibody panels designed to simplify and accelerate multiplex assay development. These panels are pre-optimized and built using validated antibodies, allowing researchers to reduce the time and effort typically required for assay setup and optimization. Among the newly introduced options are panels focused on stromal and vascular biology, enabling targeted analysis of specific components of the tissue microenvironment.
The modular design of SPYRE Focus Panels offers significant flexibility. While the panels come with ready-to-use protocols, they also allow researchers to incorporate additional markers from their own antibody libraries. This hybrid approach ensures that scientists can benefit from standardized, high-quality reagents while still customizing their experiments to address specific research questions. As a result, the panels support both efficiency and adaptability, two key requirements in modern biological research.
Complementing the SPYRE Focus Panels are the SPYRE Amplification Kits, which are designed to enhance the detection of low-abundance or difficult-to-detect targets. These kits utilize seqLA™ technology, a proprietary method that improves signal amplification without compromising specificity. Detecting low-expression biomarkers has long been a challenge in spatial biology, particularly when studying rare cell populations or subtle molecular changes. By increasing sensitivity, the amplification kits enable researchers to capture a more complete and accurate picture of biological processes.
Together, these new tools significantly strengthen the COMET workflow by enabling deeper and more focused interrogation of tissue samples. From initial assay design to final data interpretation, the integrated system supports a seamless and efficient research process. This end-to-end capability is particularly valuable in complex studies where multiple biomarkers and cellular interactions must be analyzed simultaneously.
To further enhance the user experience, Bio-Techne has also introduced new features within its HORIZON™ Image Analysis Software. These updates are specifically tailored for COMET-generated hyperplex images and are optimized to work with the new SPYRE tools. The software improvements aim to streamline tissue analysis by providing more advanced image processing, data visualization, and interpretation capabilities. By integrating hardware, reagents, and software into a cohesive ecosystem, Bio-Techne is addressing one of the key challenges in spatial biology: managing and extracting meaningful insights from large and complex datasets.
Steve Crouse, President of Bio-Techne’s Diagnostics and Spatial Biology Segment, highlighted the importance of innovation in driving the company’s strategy. He noted that researchers increasingly require tools that simplify workflows while delivering high-quality, reliable data. According to Crouse, the introduction of SPYRE Focus Panels and Amplification Kits reflects Bio-Techne’s commitment to meeting these needs by providing solutions that are not only powerful but also user-friendly.
The practical impact of these innovations is already being recognized within the scientific community. Joanne Edwards, Professor of Translational Cancer Pathology at the University of Glasgow, emphasized the advantages of using pre-optimized SPYRE panels in her research. She noted that the panels have expanded the capacity of conventional multiplex immunofluorescence techniques while significantly reducing experimental timelines. In some cases, workflows that previously required multiple days can now be completed within a single day, improving efficiency without sacrificing data quality.
Professor Edwards also highlighted the flexibility of the COMET workflow, particularly its ability to integrate custom antibodies alongside pre-validated panels. This feature allows researchers to tailor their experiments to specific scientific questions while maintaining the robustness and reproducibility of standardized protocols. Importantly, she pointed out that the technology enables simultaneous investigation of tumor cells and their surrounding microenvironment within the same tissue sample, providing a more comprehensive understanding of disease biology.
This capability is especially relevant in cancer research, where the tumor microenvironment plays a critical role in disease progression and response to therapy. By enabling detailed spatial analysis of both tumor and non-tumor cells, the COMET platform with SPYRE enhancements can support the development of more effective and targeted treatments. Beyond oncology, these tools are also applicable to a wide range of research areas, including immunology, neuroscience, and infectious diseases.
The introduction of SPYRE Focus Panels and Amplification Kits underscores Bio-Techne’s broader vision of building a fully integrated spatial biology ecosystem. By combining modular reagents, automated workflows, and advanced software, the company aims to provide researchers with a comprehensive solution that addresses the entire experimental pipeline. This integrated approach not only improves efficiency but also enhances reproducibility and scalability, which are critical for translating research findings into clinical applications.
Another important aspect of this development is its potential to accelerate preclinical research. By enabling faster and more detailed analysis of tissue samples, the COMET platform can help researchers identify promising therapeutic targets and biomarkers more quickly. This, in turn, can shorten the timeline for drug development and improve the likelihood of success in clinical trials.
Looking ahead, the expansion of the COMET portfolio reflects a growing trend toward more sophisticated and data-driven approaches in life sciences. As technologies continue to evolve, the ability to generate and interpret high-dimensional biological data will become increasingly important. Bio-Techne’s investment in spatial biology tools positions the company as a key player in this rapidly advancing field.
In summary, the addition of SPYRE Focus Panels and SPYRE Amplification Kits to the COMET platform represents a significant advancement in spatial biology technology. By enhancing flexibility, sensitivity, and workflow integration, these innovations enable researchers to gain deeper insights into complex biological systems. Supported by improvements in HORIZON Image Analysis Software, the expanded ecosystem provides a powerful and streamlined solution for tissue analysis. Through these developments, Bio-Techne continues to empower scientists to unlock new discoveries and drive progress in biomedical research and therapeutic development.
ABOUT BIO-TECHNE:
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide.
Source Link:https://investors.bio-techne.com/
